Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Aschner

Showing results (21-30 of 1,088) with videos related to

Pageof 109
Sort By:
F1000Research|August 7, 2018
GSK-3β, a double-edged sword in Nrf2 regulation: Implications for neurological dysfunction and diseaseMegan Culbreth, Michael Aschner
Advances in Nutrition (Bethesda, Md.)|May 17, 2017
ManganeseMichael Aschner, Keith Erikson
Neurotoxicity Research|September 17, 2009
Are neuropathological conditions relevant to ethylmercury exposure?Michael Aschner, Sandra Ceccatelli
Toxics|January 12, 2021
Commonalities between Copper Neurotoxicity and Alzheimer's DiseaseRoshni Patel, Michael Aschner
Neurochemical Research|September 18, 2024
Correction: Nuclear Medicine Imaging Techniques in GlioblastomasEmirhan Harbi, Michael Aschner
Molecular Biology Reports|March 5, 2025
Von Hippel-Lindau syndrome: clinical features, genetic foundations, and management strategiesEmirhan Harbi, Michael Aschner
Cellular Oncology (Dordrecht, Netherlands)|December 10, 2024
Role of BRCA1 in glioblastoma etiologyEmirhan Harbi, Michael Aschner
Alternatives to Laboratory Animals : ATLA|January 18, 2005
Neurotoxicology: principles and considerations of in vitro assessmentMichael Aschner, Tore Syversen
Chemical Research in Toxicology|April 8, 2016
Advanced Glycation End-Products and Their Receptors: Related Pathologies, Recent Therapeutic Strategies, and a Potential Model for Future Neurodegeneration StudiesAdi Pinkas, Michael Aschner
Brain Research. Molecular Brain Research|February 8, 2003
Methylmercury-induced reactive oxygen species formation in neonatal cerebral astrocytic cultures is attenuated by antioxidantsGouri Shanker, Michael Aschner
Pageof 109

Showing results (21-30 of 1,088) with videos related to

Sort By:
Pageof 109
F1000Research|August 7, 2018
GSK-3β, a double-edged sword in Nrf2 regulation: Implications for neurological dysfunction and diseaseMegan Culbreth, Michael Aschner
Advances in Nutrition (Bethesda, Md.)|May 17, 2017
ManganeseMichael Aschner, Keith Erikson
Neurotoxicity Research|September 17, 2009
Are neuropathological conditions relevant to ethylmercury exposure?Michael Aschner, Sandra Ceccatelli
Toxics|January 12, 2021
Commonalities between Copper Neurotoxicity and Alzheimer's DiseaseRoshni Patel, Michael Aschner
Neurochemical Research|September 18, 2024
Correction: Nuclear Medicine Imaging Techniques in GlioblastomasEmirhan Harbi, Michael Aschner
Molecular Biology Reports|March 5, 2025
Von Hippel-Lindau syndrome: clinical features, genetic foundations, and management strategiesEmirhan Harbi, Michael Aschner
Cellular Oncology (Dordrecht, Netherlands)|December 10, 2024
Role of BRCA1 in glioblastoma etiologyEmirhan Harbi, Michael Aschner
Alternatives to Laboratory Animals : ATLA|January 18, 2005
Neurotoxicology: principles and considerations of in vitro assessmentMichael Aschner, Tore Syversen
Chemical Research in Toxicology|April 8, 2016
Advanced Glycation End-Products and Their Receptors: Related Pathologies, Recent Therapeutic Strategies, and a Potential Model for Future Neurodegeneration StudiesAdi Pinkas, Michael Aschner
Brain Research. Molecular Brain Research|February 8, 2003
Methylmercury-induced reactive oxygen species formation in neonatal cerebral astrocytic cultures is attenuated by antioxidantsGouri Shanker, Michael Aschner
Pageof 109